Showing results (561-570 of 638) with videos related to
Sort By:
Pageof 64
Molecular Cancer Therapeutics|November 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4Alejandro Villar-Prados, Sherry Y Wu, Karem A Court, et al.Oncotarget|March 5, 2015
Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growthGuillermo N Armaiz-Pena, Vianey Gonzalez-Villasana, Archana S Nagaraja, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancerPablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.Gynecologic Oncology|February 10, 2021
Clinical significance of homologous recombination deficiency score testing in endometrial CancerJean H Siedel, Kari L Ring, Wei Hu, et al.Molecular Therapy. Nucleic Acids|December 17, 2017
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer ModelsPinar Kanlikilicer, Bulent Ozpolat, Burcu Aslan, et al.Journal of the National Cancer Institute. Monographs|November 16, 2017
State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion ReportDan Xi, Ting Bao, Qi Chen, et al.Cancer Cell|July 23, 2013
A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesisMassimo Masiero, Filipa Costa Simões, Hee Dong Han, et al.Journal of the National Cancer Institute|September 30, 2011
Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell deathAlpa M Nick, Rebecca L Stone, Guillermo Armaiz-Pena, et al.Cancer Research|May 1, 2010
Sustained small interfering RNA delivery by mesoporous silicon particlesTakemi Tanaka, Lingegowda S Mangala, Pablo E Vivas-Mejia, et al.Molecular Cancer Therapeutics|October 5, 2014
Therapeutic silencing of KRAS using systemically delivered siRNAsChad V Pecot, Sherry Y Wu, Seth Bellister, et al.Pageof 64